Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management
Ayalew Tefferi
, Tiziano Barbui
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Polycythemia Vera
100%
Risk Management
84%
Thrombosis
52%
INCB018424
30%
Mutation
27%
Abnormal Karyotype
26%
Busulfan
25%
Leukocytosis
21%
Pruritus
19%
Hematocrit
19%
Cytogenetics
19%
Venous Thrombosis
18%
Acute Myeloid Leukemia
18%
Survival
16%
Alleles
14%
Bone Marrow Examination
13%
Therapeutics
12%
Thrombocytosis
12%
Perioperative Care
12%
Polycythemia
12%
Primary Myelofibrosis
12%
Y Chromosome
11%
Hydroxyurea
11%
Phlebotomy
11%
Splenomegaly
10%
Viscera
10%
Contraindications
9%
Aspirin
8%
Interferons
8%
Veins
8%
Pharmaceutical Preparations
7%
Hemoglobins
7%
Neutrophils
7%
Pregnancy
5%
Incidence
4%
Neoplasms
3%